Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial.

Cohran, Valeria

Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial. [electronic resource] - Journal of pediatric rehabilitation medicine 2013 - 85-93 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1875-8894

10.3233/PRM-130242 doi


Absorptiometry, Photon
Adolescent
Adult
Alkaline Phosphatase--blood
Biomarkers--blood
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Cerebral Palsy--pathology
Child
Collagen Type I--blood
Double-Blind Method
Etidronic Acid--administration & dosage
Female
Humans
Lumbar Vertebrae--diagnostic imaging
Male
Osteocalcin--blood
Peptides--blood
Risedronic Acid
Treatment Outcome
Young Adult